.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Medtronic
Chubb
Johnson and Johnson
Federal Trade Commission
Farmers Insurance
US Department of Justice
Deloitte
Daiichi Sankyo

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071525

« Back to Dashboard
NDA 071525 describes TRAZODONE HYDROCHLORIDE, which is a drug marketed by Mylan, Watson Labs, Alvogen, Mylan Pharms Inc, Quantum Pharmics, Accord Hlthcare, Teva Pharms Usa, Pliva, Sun Pharm Inds, Am Therap, Teva, Apotex, Torrent Pharms Ltd, Sandoz, Aurolife Pharma Llc, Usl Pharma, Vintage, and Apotex Inc, and is included in twenty-seven NDAs. It is available from forty-four suppliers. Additional details are available on the TRAZODONE HYDROCHLORIDE profile page.

The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are thirteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.

Summary for NDA: 071525

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 071525

Suppliers and Packaging for NDA: 071525

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL 071525 ANDA Blenheim Pharmacal, Inc. 10544-533 10544-533-30 30 TABLET in 1 BOTTLE (10544-533-30)
TRAZODONE HYDROCHLORIDE
trazodone hydrochloride
TABLET;ORAL 071525 ANDA STAT RX LLC USA 16590-585 16590-585-28 28 TABLET in 1 BOTTLE (16590-585-28)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength150MG
Approval Date:Mar 9, 1988TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
McKesson
Deloitte
Express Scripts
Johnson and Johnson
US Department of Justice
Baxter
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot